PX Biosolutions is a biotech company developing a novel vaccine adjuvant platform technology, DCtag, with prophylactic and therapeutic utility in both human and animal applications.
PX Biosolutions is a biotech company developing a novel vaccine adjuvant platform technology, DCtag, with prophylactic and therapeutic utility in both human and animal applications.
CiMaas BV is a biotech company developing cellular immunotherapy for specific groups of cancer patients. CiMaas focuses on the development of two unique products: a cancer vaccine using the patient’s own immune (dendritic) cells and the production of donor natural killer cells. These methods can help to treat many oncological diseases.
Bellicum Pharmaceuticals is a biopharma company developing novel cellular immunotherapies for various forms of cancer (both hematological and solid tumors), as well as orphan inherited blood disorders.